Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
62,036,250
-
Total 13F shares
-
60,791,422
-
Share change
-
+1,192,784
-
Total reported value
-
$9,189,438,728
-
Put/Call ratio
-
99%
-
Price per share
-
$151.17
-
Number of holders
-
188
-
Value change
-
+$198,420,492
-
Number of buys
-
110
-
Number of sells
-
81
Institutional Holders of Ascendis Pharma A/S - American Depositary Shares (ASND) as of Q1 2024
As of 31 Mar 2024,
Ascendis Pharma A/S - American Depositary Shares (ASND) was held by
188 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,791,422 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Artisan Partners Limited Partnership, FMR LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, Avoro Capital Advisors LLC, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, T. Rowe Price Investment Management, Inc., Capital International Investors, and FRANKLIN RESOURCES INC.
This page lists
188
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.